Adverse Drug Reactions Monitoring

Patients with cardiovascular disease are particularly vulnerable to adverse drug reactions (ADRs). ADR occur frequently in modern medical practice, increasing mortality and morbidity and inflating the cost of care. Patients with cardiovascular disease are vulnerable due to their polypharmacy, advanced age, and the influence of heart disease on drug metabolism. The ADR potential for a particular cardiovascular drug varies the extent of exposure to other drugs, the disease being treated, and the individual.

 

  • World Health Organization (WHO)
  • International Conference on Harmonization (ICH)
  • Suspected ADR reporting forms
  • Individual Case Safety Reports

Related Conference of Adverse Drug Reactions Monitoring

October 20-21, 2026

15th World Heart Congress

London, UK
November 09-10, 2026

7th Annual Summit on Cardiology and Heart Diseases

Paris, France
November 16-17, 2026

8th World Heart Congress

Tokyo, Japan
November 23-24, 2026

40th World Congress on Heart Diseases

Toronto, Canada
November 25-26, 2026

33rd World Heartcare Summit

Paris, France
January 26-27, 2027

12th International Heart Conference

Dubai, UAE
March 18-19, 2027

16th World Heart Congress

Paris, France
May 13-14, 2027

10th Annual Heart Rhythm Conference

Rome, Italy
June 17-18, 2027

10th World Heart and Brain Conference

London, UK
June 21-22, 2027

8th European Summit on Cardiology Research

Zurich, Switzerland

Adverse Drug Reactions Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in